Peter G. Rose, MD

Hillcrest Cancer Center at Hillcrest ...Mayfield Heights, Ohio - 44124 (216-444-9797) |
- CLINICAL TRIALS 6
- CONDITIONS10
- INTERVENTIONS16
- SINCE1992

Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy Paclitaxel and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
March 2009 - March 2013

Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage III or Stage IVA Endometrial Cancer
June 2009 - December 2013

Second Curettage in Treating Patients With Persistent Non-Metastatic Gestational Trophoblastic Tumor
October 2007 - June 2010

Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
August 2009 - February 2015

Collecting Tumor Samples From Patients With Gynecological Tumors
June 1992 -

Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma
November 2009 - January 2015
Ovarian Neoplasms
Fatigue
Neurotoxicity Syndromes
Endometrial Neoplasms
Sarcoma
Trophoblastic Neoplasms
Gestational Trophoblastic Neoplasms
Leiomyosarcoma
Hydatidiform Mole
Carcinosarcoma
Placebo
Intensity-Modulated Radiation Therapy
Laboratory Biomarker Analysis
Filgrastim
Paclitaxel
Carboplatin
Bevacizumab
Cisplatin
Docetaxel
Gemcitabine Hydrochloride
Ifosfamide
Radiation Therapy
Pegfilgrastim
Conventional Surgery
Biologic Sample Preservation Procedure
Brachytherapy



